Physician

Brian Chi-Ming Fong, MD

According to 2025 Medicare claims, Brian Fong, MD (NPI: 1407888910) practices urology in the Everett, WA market, with the plurality of this provider's patient population coming from Snohomish, WA. This provider's primary affiliated billing organization is PROVIDENCE HEALTH & SERVICES- WASHINGTON (NPI: 1124270715; TIN: 320261234) and primary practice location at 98203-2338. Fong is affiliated with the Health Connect Partners, LLC (ACO ID: A2342), Jefferson Accountable Care, LLC (ACO ID: A5275), and PSW ACO (ACO ID: A5323), participating under the MSSP model.

Fong's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 446 traditional Medicare patients, billed 1,940 HCPCS/CPT codes, and received $164,740 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 4,046 prescription claims across 869 beneficiaries totaling $323,389 in drug costs, led by Erleada (Apalutamide). DME data shows 58 claims. Open Payments data shows 36 records totaling $2,216. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $151,568 to $323,389. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	444	5,631	$128,584
2016	477	5,081	$142,945
2017	514	7,818	$151,182
2018	463	6,172	$154,273
2019	476	4,248	$173,645
2020	485	2,474	$168,611
2021	503	2,143	$189,784
2022	524	2,041	$197,296
2023	477	1,661	$162,568
2024	446	1,940	$164,740

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	471	2,602	$151,568
2016	515	2,829	$186,669
2017	544	2,613	$170,277
2018	487	2,537	$174,293
2019	519	2,523	$171,513
2020	619	2,985	$178,850
2021	656	3,182	$301,049
2022	733	3,642	$337,554
2023	793	3,903	$343,553
2024	869	4,046	$323,389

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	62	$23,440
2016	N/R	73	$40,639
2017	N/R	73	$37,722
2018	N/R	110	$49,195
2019	N/R	101	$41,970
2020	12	109	$38,604
2021	13	111	$30,576
2022	N/R	66	$26,791
2023	N/R	71	$27,998
2024	N/R	58	$33,801

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	104	117	$186
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	76	76	$107
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	381	582	$85
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	210	242	$13
51798	Ultrasound measurement of bladder capacity after voiding	187	243	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	12	360	$181,804
Myrbetriq	Mirabegron	54	3,390	$49,585
Tamsulosin Hcl	Tamsulosin Hcl	1,363	107,049	$29,039
Finasteride	Finasteride	1,052	85,868	$14,322
Bethanechol Chloride	Bethanechol Chloride	103	5,550	$4,067

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	26	$21,288
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	32	$12,512

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	36	$2,216	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian Chi-Ming Fong, MD?

Tedicare shows public-source Medicare data for Brian Chi-Ming Fong, MD (NPI 1407888910), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian Chi-Ming Fong, MD have ACO affiliation data?

Brian Chi-Ming Fong, MD is shown with ACO affiliation data for Health Connect Partners, LLC (MSSP, ACO ID A2342), Jefferson Accountable Care, LLC (MSSP, ACO ID A5275), and PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Brian Chi-Ming Fong, MD?

Brian Chi-Ming Fong, MD is linked to PROVIDENCE HEALTH & SERVICES- WASHINGTON (billing NPI 1124270715) in the available physician profile data.

Does Brian Chi-Ming Fong, MD have Open Payments data?

Brian Chi-Ming Fong, MD has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.